equine programme

Tuesday 23 June 2026

7amRegistration opens
Level 3
8amWelcome | Rob Mills (NZVA President)
Theatre 1
Level 5
8.10amPlenary: Learning through times of disruption: navigating AI | Sir Ashley Bloomfield
Theatre 1
Level 5
9amMorning tea

Exhibition Hall
Level 3
9.30amAxial skeletal pain - anatomy and diagnosis | Katie Seabaugh
Room 502 
Level 5
10.25amAxial skeletal pain - treatment | Katie Seabaugh
Room 502 
Level 5
11.15amEquine Veterinarian Branch AGM
Room 502 
Level 5
12pmLunchExhibition Hall
Level 3
1pmAcupuncture in equine practice: evidence based application | Huisheng Xie
Room 502 
Level 5
2pmAcupuncture in equine practice: case examples | Huisheng Xie
Room 502 
Level 5
3pmAfternoon tea
Exhibition Hall
Level 3
3.30pmBack country equine helicopter rescue | Mat O'Sullivan
Room 502 
Level 5
3.45pmSeptic suspensory desmitis: a case series | Casey Riley
Room 502 
Level 5
4pmOvarian haemorrhage causing hemoperitoneum in a 9-year-old miniature horse | Sophia Jolly
Room 502 
Level 5
4.15pmMaxillary sinus feed impaction due to oro-antral fistula formation | Jemma Fenton
Room 502 
Level 5
4.30pmJuvenile disseminated haemangiosarcoma in a thoroughbred foal | Maëva Saint-Omer
Room 502 
Level 5
4.45pmRetrospective safety analysis of 2.5% polyacrylamide hydrogel in flat-racing thoroughbreds | Jason Lowe
This presentation examines the long‑term clinical safety of repeated intra‑articular administration of 2.5% injectable polyacrylamide hydrogel (iPAAG) in flat racing Thoroughbred horses. Drawing on six years of real‑world clinical data from over 700 horses and 2,300 injections, the talk will explore adverse joint reactions, catastrophic musculoskeletal injury (CMSI) risk, and racing career outcomes. Findings show a very low incidence of clinically significant complications, no association with increased CMSI, and no detrimental effect on racing performance, supporting iPAAG as a joint‑ preserving option for managing osteoarthritis in performance horses.
Room 502 
Level 5
5pmDiagnostic imaging findings in horses presented for poor performance investigations | Alice Addis
Room 502 
Level 5
5.15pmSurprising benefits of CT for a racetrack vet | Sam Taylor
Room 502 
Level 5
5.30pmHappy hourExhibition Hall
Level 3
7pmNZVA Special Interest Branch Dinners and NZVNA Dinner
Room 502 
Level 5

Wednesday 24 June 2026

7amRegistration opens
Level 3
8amPlenary: Thriving and striving at work - the ultimate win win | Charlotte Cantley
Theatre 1
Level 5
8.45amNZVA AGMTheatre 1
Level 5
9.30amMorning tea
Exhibition Hall
Level 3
10amIntra-articular injection techniques | Katie Seabaugh
Room 502 
Level 5
11.10amModalities for pain management | Katie Seabaugh
Room 502 
Level 5
12.30pmLunchExhibition Hall
Level 3
1.30pmTo be confirmed
Room 502 
Level 5
3.30pmAfternoon teaExhibition Hall
Level 3
4pmProfessional indemnity - stories from the trenches! | Paul Fraser
This presentation deals with professional indemnity and regulatory claims involving horses that were processed by the Veterinary Professional Insurance Society (VPIS) during the preceding 12 months. 
Room 502 
Level 5
4.30pmGouldie hour | Joe Mayhew and Katie Seabaugh
The Gouldie hour was initiated at the 2013 NZEVA Conference to recognise the considerable contributions made by Dr Brian Goulden to undergraduate, to post-graduate, and to continuing equine veterinary education in New Zealand. As continued celebration of Brian’s superb input to equine veterinary science, Katie Seabaugh and Joe Mayhew will attempt to titillate, annoy, stimulate, entertain, challenge, and hopefully edify colleagues on papers and issues from the current equine veterinary literature. A bit of science, a bit of blarney, a bit of wrangling, and maybe some skepticism?
Room 502 
Level 5
5.45pmNZVA AwardsTheatre 1
Level 5
6.30pmNetworking dinnerExhibition Hall
Level 3

Thursday 25 June 2026

7amRegistration opens
Level 3
7.30amCeva breakfastTo be confirmed
9amAMR surveillance and audits - an update for equine veterinarians | Lucy Johnston
Learn about the Ministry for Primary Industries antimicrobial resistance (AMR) programme as it relates to equine practice, including surveillance for AMR, trends in antibiotic sales, and AMR audit findings. 
AMR surveillance relevant to the equine industry will be presented highlighting emerging trends and implications for veterinary practice. MPI’s new AMR dashboard: an interactive tool designed to make surveillance data accessible and actionable to practitioners will be introduced. 
The session will include a brief overview of the AMR team’s broader work, including outcomes of the AMR audits.
Room 502 
Level 5
9.15am
Treatment of gastric disease: effective, ineffective or simply misguided? | David Rendle
Room 502 
Level 5
10amMorning tea
Exhibition Hall
Level 3
10.30amTo be confirmed
Room 502 
Level 5
11.30amCases: 50 shades of lame | Katie Seabaugh
Room 502
Level 5
12.30pmLunchExhibition Hall
Level 3
1.30pm
Prevalence of nasopharyngeal cicatrix syndrome in thoroughbred broodmares in New Zealand | Laurinda Oliver
Room 502 
Level 5
2pm"Under the care" and what it will mean for equine practice | Michelle Logan
Room 502 
Level 5
2.15pmUpdate on New Zealand equine parasite management guidelines | Holly Blue
Room 502 
Level 5
2.30pmParasite management - practical advice for horse owners | Victoria Chapman
Room 502 
Level 5
2.45pmLessons from New Zealand's greyhound racing shutdown for equine-use sports | Gavin Goble
Room 502 
Level 5
3pmAI (Artificial Intelligence) in equine clinical practice: practical uses, real risks, and how to start | Sarah Rosanowski
Room 502 
Level 5
3.15pmFrom microchips to biosecurity: NEIT updates for equine clinicians | Sarah Rosanowski
Room 502 
Level 5
3.30pmAfternoon teaExhibition Hall
Level 3
4pmAfter hours project - where it has landed | Brendan Hickman

Shared talk with Veterinary Business stream
Room 504
Level 5

Combined session with another stream.

This programme was correct at the time of publication. Speakers and titles are subject to change.